Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease

Circulation Journal

Volumn 71, Issue 7, 2007, Pages 1052-1059

  Higashi, Kouji ^a   Terai, Masaru ^a   Hamada, Hiromichi ^a   Honda, Takafumi ^a   Kanazawa, Masaki ^a   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Endothelial cell; Inflammation; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN; WARFARIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BIOASSAY; CELL PROLIFERATION; CELL STIMULATION; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE SEVERITY; ENDOTHELIUM CELL; FEVER; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO SELECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; SERUM; STATISTICAL SIGNIFICANCE; THROMBOSIS; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; ANTICOAGULANTS; ASPIRIN; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; GLUCOCORTICOIDS; HEPARIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEOVASCULARIZATION, PHYSIOLOGIC; PREDNISOLONE; SERUM; SEVERITY OF ILLNESS INDEX; UMBILICAL VEINS; WARFARIN;

EID: 34347254196     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1052     Document Type: Article

References (21)

1. Nakamura Y, Yanagawa H, Kawasaki T. Mortality among children with Kawasaki disease in Japan. N Engl J Med 1992; 326: 1246-1249.
2. Yoshikawa H, Nomura Y, Masuda K, Hazeki D, Yotsumoto K, Arata M, et al. Four cases of Kawasaki syndrome complicated with myocarditis. Circ J 2006; 70: 202-205.
3. Baba R, Shibata A, Tsurusawa M. Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity. Circ J 2005; 69: 962-964.
4. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease. J Pediatr 1986; 108: 923-928.
5. Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease. I: Pathology and morphogenesis of the vascular changes. Jpn Circ J 1979; 43: 633-643.
6. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, Wiegand SJ, et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004; 110: 2430-2435.
7. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48: 247-251.
8. Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, et al. The acute phase nature of interleukin 6: Studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989; 76: 337-342.
9. Terai M, Jibiki T, Harada A, Terashima Y, Yasukawa K, Tateno S, et al. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 1999; 65: 566- 572.
10. Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998; 44: 596-599.
11. Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999; 83: 337-339.
12. Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Hashimoto I, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: Its possible role in progression of coronary artery lesions. Pediatr Res 2001; 49: 74-80.
13. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993; 91: 977-985.
14. Cid MC, Hernandez-Rodriguez J, Esteban MJ, Cebrian M, Gho YS, Font C. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation 2002; 106: 1664-1671.
15. Jibiki T, Terai M, Kurosaki T, Nakajima H, Suzuki K, Inomata H, et al. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur J Pediatr 2004; 163: 229-233.
16. Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci 2006; 47: 2369-2380.
17. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-716.
18. Chen W, Lee JY, Hsieh WC. Effects of dexamethasone and sex hormones on cytokine-induced cellular adhesion molecule expression in human endothelial cells. Eur J Dermatol 2002; 12: 445-448.
19. Jung SP, Siegrist B, Wade MR, Anthony CT, Woltering EA. Inhibition of human angiogenesis with heparin and hydrocortisone. Angiogenesis 2001; 4: 175-186.
20. Takeshita S, Kawamura Y, Takabayashi H, Yoshida N, Nonoyama S. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clin Exp Immunol 2005; 139: 575-579.
21. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease Circ J 2005; 69: 265-272.